Oral and dental management for people with multiple myeloma: clinical guidance for dental care providers
| Autor: | Hassan Abed, Mary Burke, Najla Nizarali |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry Cancer 030206 dentistry Neutropenia medicine.disease Dental care stomatognathic diseases 03 medical and health sciences 0302 clinical medicine Increased risk hemic and lymphatic diseases 030220 oncology & carcinogenesis medicine Clinical significance medicine.symptom Intensive care medicine Bone pain Osteonecrosis of the jaw business General Dentistry Multiple myeloma |
| Zdroj: | Dental Update. 45:383-399 |
| ISSN: | 2515-589X 0305-5000 |
| DOI: | 10.12968/denu.2018.45.5.383 |
| Popis: | Abstract: Multiple myeloma (MM) is defined as cancer of the plasma cells that is characterized by the production of abnormal immunoglobulin. It most commonly presents in people over 65 years of age, with a higher prevalence in men. People with MM can present with bone pain, renal failure, anaemia, thrombocytopenia and neutropenia, which can arise from the condition itself or from its treatment. A large proportion will be treated with intravenous bisphosphonates, therefore putting them at an increased risk of developing medication-related osteonecrosis of the jaw (MRONJ). This paper aims to provide guidance on the oral and dental management of people with multiple myeloma. CPD/Clinical Relevance: To provide an update to dental care providers on the oral and dental management of people with multiple myeloma and provide a guide on what factors to consider when deciding on the most appropriate setting for the provision of their dental care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|